Cumulative Incidence and Clinical Risk Factors of Radiation Cystitis after Radiotherapy for Prostate Cancer
Urologia Internationalis · 2023 · 107 (5) · 440-446
DOI: 10.1159/000521723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Urologia Internationalis, online erschienen am 15.03.2022. Verfasst von Katsuhiro Makino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Radiation Injuries, Cystitis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
This study aimed to evaluate the cumulative incidence of overall and severe radiation cystitis following external beam radiation therapy for prostate cancer and investigate the clinical factors predictive of radiation cystitis.
Methods
This retrospective study comprised 246 patients who received external beam radiation therapy for localized or locally advanced prostate cancer between 2013 and 2016 in our institution. Of these, 189 received primary radiation therapy and 57 received adjuvant/salvage radiation therapy. Radiation cystitis was recorded using the Common Terminology Criteria for Adverse Events version 5.0 definition, and severe radiation cystitis was defined as grade 3 or higher. All medical records were reviewed to calculate the cumulative incidence of radiation cystitis. Univariate and multivariate Cox regression analyses were used to evaluate its association with clinicopathologic features.
Results
The median follow-up period after radiation therapy was 56 months (range 5–81). The 5-year cumulative incidence of radiation cystitis and severe radiation cystitis was 16.2% and 3.0%, respectively. Multivariate analyses identified radiation therapy in the adjuvant/salvage setting was the sole risk factor associated with the development of radiation cystitis (hazard ratio: 2.75, p = 0.02).
Conclusions
Radiation therapy in the post-prostatectomy setting was associated with increased risk of radiation cystitis compared with radiotherapy as the primary treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan.
Zitieren
APA
Makino, K., Sato, Y., Takenaka, R., Yamashita, H., Akiyama, Y., Yamada, Y., Nakamura, M., Kawai, T., Yamada, D., Suzuki, M., & Kume, H. (2023). Cumulative Incidence and Clinical Risk Factors of Radiation Cystitis after Radiotherapy for Prostate Cancer. Urologia Internationalis, 107(5), 440-446. https://doi.org/10.1159/000521723
Vancouver
Makino K, Sato Y, Takenaka R, Yamashita H, Akiyama Y, Yamada Y, et al. Cumulative Incidence and Clinical Risk Factors of Radiation Cystitis after Radiotherapy for Prostate Cancer. Urologia Internationalis. 2023;107(5):440-446. doi:10.1159/000521723
BibTeX
@article{Makino2023,
author = {Makino, Katsuhiro and Sato, Yusuke and Takenaka, Ryosuke and Yamashita, Hideomi and Akiyama, Yoshiyuki and Yamada, Yuta and Nakamura, Masaki and Kawai, Taketo and Yamada, Daisuke and Suzuki, Motofumi and Kume, Haruki},
title = {Cumulative Incidence and Clinical Risk Factors of Radiation Cystitis after Radiotherapy for Prostate Cancer},
journal = {Urologia Internationalis},
year = {2023},
volume = {107},
number = {5},
pages = {440--446},
doi = {10.1159/000521723}
}
EUVIMED